FAIM-L regulation of XIAP degradation modulates synaptic long-term depression and axon degeneration by Martínez-Mármol, Ramón et al.
1Scientific RepoRts | 6:35775 | DOI: 10.1038/srep35775
www.nature.com/scientificreports
FAIM-L regulation of XIAP 
degradation modulates Synaptic 
Long-Term Depression and Axon 
Degeneration
Ramón Martínez-Mármol1,2,*,†, Bruna Barneda-Zahonero2,3,4,*, David Soto5,6,7, 
Rosa Maria Andrés1,2, Elena Coccia2,3,4, Xavier Gasull5,6,7, Laura Planells-Ferrer2,3,4, 
Rana S. Moubarak2,3,4, Eduardo Soriano1,2,3,6,8 & Joan X. Comella2,3,4
Caspases have recently emerged as key regulators of axonal pruning and degeneration and of long-
term depression (LTD), a long-lasting form of synaptic plasticity. However, the mechanism underlying 
these functions remains unclear. In this context, XIAP has been shown to modulate these processes. 
The neuron-specific form of FAIM protein (FAIM-L) is a death receptor antagonist that stabilizes XIAP 
protein levels, thus preventing death receptor-induced neuronal apoptosis. Here we show that FAIM-L 
modulates synaptic transmission, prevents chemical-LTD induction in hippocampal neurons, and 
thwarts axon degeneration after nerve growth factor (NGF) withdrawal. Additionally, we demonstrate 
that the participation of FAIM-L in these two processes is dependent on its capacity to stabilize XIAP 
protein levels. Our data reveal FAIM-L as a regulator of axonal degeneration and synaptic plasticity.
The long form of Fas Apoptotic Inhibitory Molecule (FAIM) protein, FAIM-L, expressed solely in neurons, is 
a Death Receptor (DR) antagonist that protects neurons from DR-induced apoptosis1. We recently reported 
the mechanism through which FAIM-L safeguards neurons from Fas Ligand (FasL)-induced apoptosis. In this 
regard, FAIM-L interacts with XIAP through an IAP-Binding Motif (IBM) located at its N-terminus. This associa-
tion impairs XIAP auto-ubiquitinylation and degradation by the proteasome, hence enabling XIAP to confer pro-
tection against FasL-induced apoptosis by inhibiting caspase-3 activation2. Accordingly, we addressed whether 
XIAP stabilization by FAIM-L, leading to precise regulation of caspase-3, is involved not only in neuronal apop-
tosis but also in non-apoptotic physiological functions of XIAP in neurons.
During nervous system development, once neurons are integrated into circuits, apoptotic signaling is 
restricted to specific cellular compartments in order to maintain neuronal viability. Neural connections form a 
dynamic system, and many neurological processes participate in its final configuration and remodeling, such as 
axon-selective pruning or long-term regulation of synaptic plasticity. In this context, the apoptotic machinery has 
emerged as a critical component of these processes. In recent years, caspases-3, -6, -7 and -9 have been implicated 
either in axon degeneration3–5 and/or the regulation of neuronal synaptic plasticity6–8.
X-linked inhibitor of apoptosis protein (XIAP) tightly regulates caspase activation. XIAP interacts with the 
effector caspases-3 and -7 through the baculovirus inhibitor repeat (BIR) 2 domain9–11 and with the activator 
caspase-9 through the BIR3 domain12. The XIAP-caspase interaction inhibits the catalytic activity of caspases, 
thus modulating their cellular functions. Indeed, XIAP is involved in the regulation of the non-apoptotic 
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Figure 1. FAIM-L modulates the stability of XIAP protein levels in hippocampal neurons. (A) Confocal 
images of hippocampal neurons (15 DIV) infected with lentivirus containing EMPTY-EGFP, FAIM-L-EGFP, 
FAIM-L-shRNA or scrambled shRNA and immunolabeled against GFP (second column, green) and XIAP 
(third column, red). The scale bar represents 20 μ m. (B) Quantification of XIAP staining relative to neuronal 
surface. A.U represent pixel intensities/μ m2. N = 15 to 25 neurons from 3 independent experiments, for each 
group. Data represent mean ± SEM and One-way ANOVA followed by Tukey’s multiple comparison post-hoc 
test was used to calculate significant levels between the indicated groups. *p < 0.05; **p < 0.01; ***P < 0.001; 
****p < 0.0001. (C) Hippocampal neurons were infected with lentiviral vectors as indicated. Protein levels of 
XIAP and FAIM-L were determined by Western blot 48 h after infection with overexpressing and silencing 
vectors. Data are represented as the mean ± standard error of the mean (SEM) of three independent 
experiments. One-way ANOVA followed by Tukey’s multiple comparison post-hoc test was used to calculate 
significant levels between the indicated groups. *p < 0.05; **p < 0.01.
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Figure 2. FAIM-L affects NMDA-induced AMPA receptor internalization in hippocampal neurons by 
inducing endogenous XIAP stabilization. Antibody-feeding internalization assay for endogenous GluA2 in 
hippocampal neurons stimulated with NMDA (50 μ M for 15 min, (B,D,F,H). Neurons were previously infected 
with lentivirus containing with the shRNA vectors (scrambled –A,B,C,D– or XIAP –E,F,G,H–) and after 48 h 
were re-infected with either EMPTY-EGFP (A,B,E,F) or FAIM-L-EGFP (C,D,G,H) vectors, as indicated. The 
figure shows triple-label immunostaining for infected GFP-positive neurons (first and second column), surface-
www.nature.com/scientificreports/
4Scientific RepoRts | 6:35775 | DOI: 10.1038/srep35775
functions of caspases. It controls caspase activity in degenerating axons13 and once the axon is degenerating, 
XIAP is also responsible for restricting caspase activation to this specific subcellular compartment4. XIAP has also 
been linked to the control of synaptic plasticity, thus its regulation of caspase-3, -7 and -9 activation modulates 
long-term depression (LTD)-induced AMPA receptor (AMPAR) internalization6. However, the contribution of 
FAIM-L-mediated XIAP stabilization to these non-apoptotic functions of XIAP has not been explored.
Here we examined the relevance of FAIM-L-mediated XIAP stabilization in two critical non-apoptotic pro-
cesses, namely axon degeneration and synaptic plasticity. We report that the precise regulation of XIAP protein 
levels by FAIM-L affects the synaptic plasticity of hippocampal neurons exposed to NMDA-induced LTD, as well 
as the axon degeneration of dorsal root ganglion neurons (DRGs) induced by NGF withdrawal. Our data suggest 
that FAIM-L plays a key role in the maintenance of life-long neuronal plasticity by regulating axon degeneration 
and synaptic plasticity.
Results
FAIM-L modulates XIAP protein levels in hippocampal neurons in vitro. Mitochondria engagement, 
and caspase-3 activation and its modulation by XIAP participate in LTD regulation, a crucial physiological pro-
cess for CNS development and homeostasis6–8. Our previous data revealed the capacity of the DR antagonist, 
FAIM-L, to stabilize XIAP levels, and thus, to protect cortical neurons from FasL-induced cell death2. Therefore, 
we first assessed the capacity of FAIM-L to regulate XIAP levels in hippocampal neurons. Cultured neurons were 
transduced with FAIM-L or empty EGFP-tagged lentiviral vectors for overexpression and shRNA-FAIM-L or 
shRNA-scrambled for gene silencing. XIAP expression was assessed by immunocytochemistry and Western blot. 
The overexpression or silencing of FAIM-L in hippocampal neurons resulted in the up-regulation or the abolish-
ment of XIAP expression, respectively (Fig. 1A–C).
FAIM-L regulates AMPAR internalization after NMDA-induced LTD in hippocampal neurons. 
Li and collaborators reported that XIAP and other members of the intrinsic apoptotic pathway regulate the inter-
nalization of the AMPAR subunit GluA2 after chemical-LTD induction. They proved that XIAP overexpression 
blocks NMDA-induced GluA2 internalization not only in hippocampal cultures, but also in CA1 organotypic 
slice cultures, where XIAP overexpression abrogated the LTD induced by low frequency stimulation6. Since we 
observed that FAIM-L regulates XIAP protein stability in hippocampal neurons, we next assessed its relevance in 
LTD. To address this issue, we used an in vitro model of LTD (chemical-LTD) that consists of NMDA treatment of 
hippocampal neurons for 15 min. The induction of LTD is monitored by the internalization of AMPAR subunits, 
such as GluA1 and GluA2. AMPAR endocytosis was measured in dissociated hippocampal neurons by means 
of an “antibody feeding” internalization assay14. Hippocampal neurons were infected with FAIM-L or empty 
EGFP-Tagged lentiviruses for overexpression, together with shRNA-XIAP, shRNA-FAIM-L or shRNA-scrambled 
for gene silencing (Figs 2 and 3). At 15–18 DIV, cultures were treated with 50 μ M NMDA for 15 min at 37 °C 
to stimulate chemical-LTD-induced GluA2 internalization. In control conditions (see + shRNA-scrambled, 
+ EMPTY-EGFP; Fig. 2A,B,I), the internalization was reduced when FAIM-L was overexpressed, as no significant 
differences were observed when comparing GluA2 internalized levels after treatment with control medium or 
NMDA in this condition (see + shRNA-scrambled, + FAIML-EGFP; Fig. 2C,D,I). In agreement with the obser-
vations of Li et al.6, we found that NMDA-induced GluA2 internalization was greatly increased when XIAP 
was knocked down using specific shRNA (see + shRNA-XIAP, + EMPTY-EGFP; Fig. 2E,F,I). Moreover, the 
reduction of GluA2 internalization caused by FAIM-L overexpression was not detected after XIAP silencing, 
thus further strengthening the notion that FAIM-L exerts its effect through the stabilization of XIAP protein 
(see + shRNA-XIAP, + FAIM-L-EGFP; Fig. 2G,H,I). The efficacy of shRNA-XIAP on XIAP expression was tested 
in Fig. 2J.
Finally, we tested the participation of endogenous FAIM-L in regulating the internalization of AMPAR sub-
unit GluA2. With this aim, we examined the levels of GluA2 internalization after NMDA treatment in neurons 
in which FAIM-L was silenced. Strikingly, GluA2 significantly enhanced internalization even in the absence of 
NMDA treatment, thereby pointing to the participation of FAIM-L in the regulation of AMPAR trafficking in 
basal conditions (see + shRNA-FAIM-L; Fig. 3C,E). Additionally, as expected, the induction of GluA2 internaliza-
tion by NMDA was higher than in the control condition (Fig. 3A–E), resembling a shRNA-XIAP-like phenotype 
(Fig. 2E,F,I). These observations strongly support the notion that FAIM-L contributes to the regulation of synaptic 
plasticity.
remaining GluA2 (third column, green in merge), internalized GluA2 (fourth column, red in merge), and 
merge (fifth column). Individual channels are shown in gray scale. Images in columns 2, 3, 4 and 5 represent 
magnifications from selected areas of the first columns. The scale bar represents 20 μ m. (I) Shows quantitation 
of internalization index for the experiment represented in (A–H) integrated fluorescence intensity of 
internalized GluA2/integrated fluorescence intensity of surface-remaining GluA2. Results were not normalized 
to untreated cells (− NMDA)6. As a consequence, A.U have no dimensions. N = 55 to 67 neurons from 3 
independent experiments, for each group. Data represent mean ± SEM and and One-way ANOVA test followed 
by Tukey’s multiple comparison post-hoc test was used to calculate significant levels between the indicated 
groups. *p < 0.05; ***P < 0.001; ****p < 0.0001. (J) control experiment to demonstrate that the used XIAP-
shRNA efficiently down-regulates the expression of its target protein. Hippocampal neurons were infected with 
lentivirus containing the scramble-shRNA vectors (upper panels) or XIAP-shRNA vectors (lower panels) and 
72 h later they were fixed and immune-stained against XIAP. In lower panels, it can be clearly appreciated that 
only neurons infected with XIAP-shRNA showed a clear reduction of XIAP protein levels. However, the XIAP 
protein levels are not affected in non-infected neurons or neurons infected with scramble-shRNA.
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Figure 3. FAIM-L actively participates in GluA2 internalization induced by chemical LTD. (A–D) 
antibody-feeding internalization assay for endogenous GluA2 in hippocampal neurons stimulated with NMDA 
(50 μ M for 15 min). Neurons were infected with lentiviruses containing the shRNA constructs (scrambled or 
FAIM-L). The figure shows triple-label immunostaining for infected GFP-positive neurons (first and second 
column), surface-remaining GluA2 (third column, green in merge), internalized GluA2 (fourth column, red  
in merge), and merge (fifth column). Individual channels are shown in grayscale. Images in columns 2, 3, 4 and 
5 represent magnifications from selected areas of the first columns. The scale bar represents 20 μ m.  
(E) quantification of GluA2 internalization in the indicated conditions calculated as in Fig. 2(I). Results were 
not normalized to untreated cells (−NMDA). As a consequence, A.U have no dimensions. N = 48 to 53 neurons 
from 3 independent experiments, for each group. Data represent means ± SEM and were analyzed by the One-
way ANOVA test followed by Newman-Keuls multiple comparison post-hoc test, ***p < 0.001, *p < 0.05.
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FAIM-L overexpression affects synaptic transmission. To study the role of FAIM-L in synaptic 
transmission, FAIM-L was overexpressed in neuronal cultures and measured the AMPAR–mediated miniature 
excitatory postsynaptic currents (mEPSCs) in the whole-cell configuration. This functional approach allowed us 
to determine whether synaptic responses are altered in pyramidal neurons overexpressing FAIM-L compared 
with neurons expressing endogenous FAIM-L levels (scrambled group). In order to detect mEPSCs, recordings 
Figure 4. FAIM-L overexpression blocks LTD induction. (A) Representative whole-cell recordings of 
AMPAR-mediated miniature excitatory postsynaptic currents (mEPSCs) of 1-second duration from cultured 
hippocampal neurons (15–17 DIV) infected with scrambled (left trace), FAIM-L EGFP (middle) and FAIM-L 
shRNA (right). Membrane potential was held at −60 mV. (B) Example of averaged mEPSCs (red lines) from 
5-min of the recordings shown in (A) This example neuron infected with scrambled (left traces) exhibited a 
mean mEPSC amplitude of − 15.66 pA (average of 341 miniature events) while the neuron overexpressing 
FAIM-L (right traces) had a mean mEPSC amplitude of − 20.48 pA (average of 500 miniature events). Left panel 
shows mean mEPSC amplitude for the neuron shown in A with FAIM-L shRNA, which display an amplitude of 
15.05 pA (average of 198 events). Individual mEPSCs for both recordings are shown in black. Note that larger 
events are found in the neuron infected with FAIM-L-EGFP. (C) AMPAR mEPSC amplitude was increased in 
FAIM-L-infected cells (− 19.93 ± 1.41 pA n = 18) compared with scrambled shRNA (− 15.43 ± 1.24 pA n = 16; 
p = 0.0237, Student t-test). (D) Example of averaged mEPSCs response before NMDA application (black traces) 
and 20 min after NMDA application (red) for the same hippocampal neuron. After recording mEPSCs in 
baseline conditions (pre-NMDA), 50 μ M NMDA was bath applied during 5 min and mEPSCs were recorded 
consecutively. LTD process was evident in scrambled shRNA and FAIM-L shRNA groups after 20 min of 
NMDA bath application, while the amplitude of mEPSCs in FAIM-L overexpressing cells was not significantly 
decreased 20 min after NMDA application. Traces shown are the average of mEPSCs from a 5 min period. 
Miniature events are scaled to pre-NMDA for comparison purposes. (E) Time course of mEPSCs amplitude 
after NMDA (50 μ M) application for scrambled (white circles; n = 8), FAIM-L (black circles; n = 6) and FAIM-L 
shRNA (grey circles; n = 10). After a 5 min baseline period of mEPSCs recording, NMDA was applied to bath 
in the absence of TTX or any other blocker for 5 min. Subsequently, miniature events were recorded again in 
extracellular solution containing blockers during 20 min. LTD was apparent 10, 15 and 20 min after NMDA in 
scrambled and FAIM-L shRNA groups (*p < 0.05, **p < 0.01; paired Student t-test vs. baseline period) while no 
significant LTD was observed even after 20 min in neurons overexpressing FAIM-L (middle panel).
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were carried out in the presence of TTX in the extracellular solution to block spontaneous evoked transmission. 
D-AP-5 and picrotoxin were also present in the solution to block NMDA and GABAA receptors. Membrane 
potential was held at − 60 mV during mEPSCs acquisition. We found that AMPAR-mediated mEPSCs amplitude 
was increased in hippocampal neurons overexpressing FAIM-L (Fig. 4A–C) compared with both scrambled and 
FAIM-L shRNA groups. Control neurons (scrambled) displayed average amplitude of − 15.43 ± 1.24 pA (n = 16), 
while FAIM-L overexpressing neurons showed increased mEPSCs amplitudes (− 19.93 ± 1.41 pA; p = 0.0237 
compared to scrambled group; n = 18; Fig. 4C). Silencing of FAIM-L (FAIM-L shRNA) did not alter mEPSCs 
compared with scrambled group (− 15.62 ± 1.22 pA; p = 0.9120; n = 15).
Our data suggest this DR antagonist modulates synaptic transmission. Li and co-workers6 discarded the par-
ticipation of caspase activation in synaptic transmission, and therefore the mechanism through which FAIM-L 
exerts its function in this context remains elusive. Nevertheless, these observations coincide with the effect on 
AMPAR internalization observed in the FAIM-L-transduced hippocampal neurons, where the over-expression of 
this protein resulted in greater internalized AMPAR in non-stimulated neurons (Fig. 2C–I).
Overexpression of FAIM-L blocks LTD. To study the role of FAIM-L in long-term depression LTD in 
pyramidal neurons (Fig. 4D,E) we measured mEPSCs amplitude before and after a treatment with NMDA (50 μ M 
during 5 min), a well-established protocol to induce chemical LTD (chem-LTD) either in the CA1 region of 
hippocampus and in hippocampal neurons in culture15,16. Miniature events were recorded in 5 min periods for a 
total of 20 min after NMDA stimulation. NMDA application produced a significant LTD as seen as a decrease in 
mEPSC amplitude as early as 10 min post-NMDA in scrambled neurons (− 15.92 ± 2.00 pA baseline pre-NMDA 
vs. − 12.94 ± 2.18 pA post-NMDA; p = 0.0326; paired student t-test; n = 8; Fig. 4D,E) and also in FAIM-L shRNA 
(− 15.65 ± 1.72 pA baseline pre-NMDA vs. − 12.16 ± 1.26 pA post-NMDA; p = 0.0022; paired student t-test; 
n = 10; Fig. 4.D,E). LTD was even more pronounced at 20 min for scrambled (− 11.40 ± 2.15 pA; n = 8; p = 0.0115 
paired Student t-test) and FAIM-L shRNA (− 11.62 ± 1.57 pA; n = 10; p = 0.033). However, no LTD was observed 
in neurons overexpressing FAIM-L GFP at any time point (− 21.08 ± 2.42 pA before NMDA vs. − 20.87 ± 2.35 pA, 
− 19.66 ± 2.79 pA, − 19.20 ± 3.07 pA and − 19.43 ± 3.16 pA at 5, 10, 15 and 20 min post NMDA respectively; 
p > 0.05 for all time points vs. pre-NMDA; paired Student t-test; n = 6; Fig. 4D,E), indicating that increased levels 
of FAIM-L in neurons preclude long-term depression changes in mEPSCs amplitude associated with NMDA 
activation. Our data support the participation of FAIM-L in synaptic transmission and in the modulation of LTD.
FAIM-L regulates axonal degeneration. During development, neurotrophins are required for cell 
survival, and they also contribute to neurite growth and maintenance. The action of these molecules results in 
an overproduction of neural connections that are later removed to form the correct patterns of connectivity. 
Both neuronal loss and selective developmental axonal degeneration contribute to the adjustment of neuronal 
connections. Although caspases mediate neuronal apoptosis, they also participate in axonal degeneration3. 
XIAP regulates caspase activation and, as expected, also participates in this process13. Since we observed that 
FAIM-L-promoted XIAP protein stabilization participated in the regulation of a non-apoptotic function of XIAP 
and caspases such as the LTD, we sought to analyze whether FAIM-L-mediated XIAP stabilization is also involved 
in axonal degeneration.
First, to address this question we took advantage of a model of axonal degeneration in DRG explant cultures. 
We dissected out the explants and infected them with the lentiviral vectors for EMPTY-EGFP or FAIM-L-EGFP. 
Axons were left to grow for 2 DIV and then subjected to NGF deprivation (Fig. 5A). Strikingly, FAIM-L levels in 
the explants were reduced under these conditions (Fig. 5B). Moreover, FAIM-L overexpression partially protected 
the explant axons from degeneration after 8–24 h of NGF withdrawal (Fig. 5A).
Many lines of evidence have been published in the field reporting that caspase-3 is involved in axonal 
degeneration related to axonal pruning during development3–5. Indeed, XIAP regulates this process through 
caspase-3 inhibition. Thus, we addressed whether FAIM-L overexpression interferes with caspase-3 activation 
during axonal degeneration. Infected explants were deprived of NGF for 8 and 24 h and caspase-3 activation 
was assessed by Westrn blot. FAIM-L overexpression reduced the generation of the caspase-3 active form p17 at 
8 h post-deprivation (Fig. 5B). It has been reported that developmental prompted axonal degeneration involves 
the activation of calpain by caspase-3 degradation of its inhibitor calpastatin. Therefore, one of the characteris-
tic features of pruning is the appearance of degraded substrates of calpains such as neurofilament 66 (NF-66)5. 
Consistent with the activation of caspase-3 observed in the explants exposed to NGF withdrawal, we detected 
fragmented forms of NF-66. In this context, the overexpression of FAIM-L induced a reduction in the caspase-3 
active fragment at 8 h and a decrease in NF-66 processing at 24 h compared to EMPTY-EGFP- infected explants 
(Fig. 5B).
Endogenous XIAP is required for FAIM-L regulation of axonal degeneration. To further char-
acterize FAIM-L modulation of axonal degeneration, we used Campenot chamber cultures. In these cultures, 
neurons are seeded in compartmented (Campenot) chambers that allow the establishment of two separate fluid 
environments. Briefly, DRGs are placed in a central chamber containing NGF, and axons grow inside the lateral 
chambers (Fig. 6A). Due to limited fluid exchange between the chambers, it is possible to achieve local neu-
rotrophin deprivation that affects only axons, while cell bodies continue to be sustained by NGF (Fig. 6A–D). 
To determine the role of the FAIM-L/XIAP axis in axonal pruning, DRG neuron bodies were transfected with 
XIAP-shRNA or scrambled-shRNA and FAIM-L-EGFP or EMPTY-EGFP overexpression constructs (Figs 6E 
and 7A–E). In agreement with what we previously described in cortical neurons2 and the results reported above 
for hippocampal neurons (Fig. 1B), FAIM-L overexpression promoted the stabilization of XIAP protein levels in 
DRG neurons (Fig. 6E). When DRG underwent local NGF deprivation, FAIM-L overexpression prevented the 
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Figure 5. FAIM-L is downregulated in NGF-deprived DRGs and its overexpression impairs axonal DRG 
degeneration induced by NGF withdrawal. DRG explants were plated in presence of lentiviral vectors carrying 
EMPTY-EGFP or FAIM-L-EGFP constructs. At DIV 2, DRG explants were subjected to NGF withdrawal. (A) at 
indicated times axonal integrity was assessed by immunocytochemistry against β III-Tubulin. Representative pictures 
for EMPT-EGFP- and FAIM-L-EGFP-infected DRGs are shown. Scale bar 200 μ m. (B) FAIM-L expression, caspase-3 
activation, and NF-66 degradation were assessed by Western blot. Histograms show FAIM-L, caspase-3 p17 fragment, 
and NF-66 cleaved fragment relative levels quantification to Histone H3, total caspase-3 and total NF-66, respectively, 
from three independent experiments in the indicated conditions. Data are represented as the mean ± standard error 
of the mean (SEM). Two-way ANOVA test followed by Bonferroni post-hoc test was used to calculate significant levels 
between the indicated groups. *p < 0.05.
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Figure 6. FAIM-L stabilizes XIAP protein levels in DRG neurons. (A) Schematic representation of a 
Campenot chamber. Cell bodies and axonal compartments were subjected (− NGF) or not (+ NGF) to NGF 
withdrawal for 24 h. (B–D) panels are representative confocal images of the DRG neurons cultured in a 
Campenot chamber. (E) DRGs neurons were infected with either EMPTY-EGFP or FAIM-L-EGFP vectors. 
Protein levels of XIAP and FAIM-L were determined by Western blot 48 h after infection with overexpressing 
and silencing vectors. In the scrambled shRNA condition, the intensity of the bands relative to the control 
(“EMPTY EGFP”) was quantified using ImageJ software. Data are represented as the mean ± SEM of three 
independent experiments. Student’s t-test was used to calculate significant levels between the indicated groups. 
**p < 0.01. Scale bar 50 μ m.
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Figure 7. FAIM-L regulates axon degeneration in vitro through endogenous XIAP stabilization.  
(A–D) Dissociated DRG neurons were plated in Campenot chambers, and distal compartments were filled 
with medium containing 75 ng/ml human NGF. After double infection with shRNAs (scrambled or XIAP) 
and overexpressing vectors (EMPTY or FAIM-L), local axonal degeneration was induced in one of the axonal 
compartments by medium replacement containing sheep anti-NGF 1:50. Cultures were fixed after 24 h and processed 
for β III-Tubulin (red) and GFP (green) immunofluorescence. (E) Histogram representing the percentage of non-
degenerating axons in (A–D) (mean and SEM, n = 4 replicates). Scale bar 50 μ m. Two-way ANOVA test followed by 
Bonferroni post-hoc test was used to calculate significant levels between the indicated groups. ***p < 0.001.
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Figure 8. Endogenous FAIM-L participates in axonal degeneration in DRG neurons. (A) Dissociated DRG 
neurons were plated in Campenot chambers, and distal compartments were filled with medium containing 
75 ng/ml human NGF. After infection with shRNAs of scrambled or FAIM-L, local axonal degeneration was 
induced in one of the axonal compartments, as described in materials and methods. Representative confocal 
images obtained at the indicated times after NGF deprivation are shown. Images are representative of three 
independent experiments. Scale bar 10 μ m. (B) DRG cultures were infected with the different lentiviral vectors 
as indicated, and NGF was withdrawn for 24 h. Caspase-3 (pro-form p32), cleaved caspase-3 (active form p17) 
and NF-66 levels were assessed at the indicated times by Western blot. ERK was used as loading control. (C) 
Histogram representing active caspase-3 levels relative to total caspase-3 and NF-66 cleaved fragment relative 
to total NF-66 in each condition 24 h after NGF withdrawal. Data are represented as the mean ± SEM of three 
independent experiments. One-way ANOVA with Tukey’s multiple comparison post-hoc test was used to 
calculate significant levels between the indicated groups. *p < 0.05. **p < 0.01.
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axonal degeneration observed after 24 h of NGF withdrawal in control DRG neurons (Fig. 7A,B,E). To test the 
relevance of FAIM-L-induced XIAP protein stabilization for the capacity of FAIM-L to prevent axon degenera-
tion, we performed the same experiment in the presence of XIAP shRNA (Fig. 7C–E). XIAP down-regulation 
abolished FAIM-L blockade of axon degeneration, thereby demonstrating that XIAP participates in the effect of 
FAIM-L on the regulation of axonal degeneration (Fig. 7E). Accordingly, the removal of endogenous FAIM-L 
levels resulted in faster degeneration when axons were exposed to NGF withdrawal (Fig. 8A). Therefore, our 
observations in the Campenot chambers support the idea that FAIM-L modulates axonal degeneration in physi-
ological conditions by stabilizing XIAP.
Finally, we determined the status of caspase-3 activation and NF-66 degradation by Western blot. The pres-
ence of FAIM-L detected after 24 h of NGF depletion resulted in a reduction of the p17 fragment of caspase-3 
and a blockade of NF-66 degradation (Fig. 8B,C). Consistent with our observations regarding axon degeneration, 
XIAP silencing was sufficient to block FAIM-L inhibition of caspase-3 activation and cleavage of NF-66 (Fig. 8B). 
These findings further support the notion that FAIM-L exerts its effect by stabilizing endogenous XIAP levels.
All together our data corroborate that the FAIM-L/XIAP/caspase axis is involved in non-apoptotic, neuronal 
physiological processes, such as axonal pruning and synaptic plasticity.
Discussion
Here we provide evidence that the DR antagonist FAIM-L regulates axon degeneration and synaptic plasticity by 
controlling XIAP protein levels. We recently characterized the mechanism underlying the role of the FAIM-L/
XIAP axis in neuronal protection against apoptosis. We described that FAIM-L interacts with XIAP through its 
IAP-binding motif and impairs its auto-ubiquitinylation and proteasomal degradation, subsequently inhibiting 
caspase activation. The inhibition of XIAP degradation protects neurons against Fas-induced apoptosis2. In the 
present work, we report other functions of the FAIM-L/XIAP axis in a neuronal physiological context that can be 
added to the previously described role of apoptosis control.
Caspases have been widely related to the resolution of apoptotic cell death17. However, these molecules are also 
activated in neuronal processes that are no longer functional and are marked for elimination18,19. In this context, 
it is reasonable to hypothesize that caspases exert functions that do not depend on cell death induction. It is par-
ticularly relevant that FAIM-L, an antagonist of apoptosis, is selectively expressed in neurons. As discussed above, 
caspases are involved in axonal pruning3–5 and in the regulation of synaptic plasticity6–8.
Mitochondria are well-suited to play a role in synaptic plasticity as this phenomenon modulates their distri-
bution, morphology and motility15. Mitochondria in dendrites take up calcium after synaptic stimulation16, and 
this uptake in turn promotes the release of pro-apoptotic factors from these organelles20,21. Thus, mitochondria 
are crucial for LTD induction. Li and colleagues reported that the induction of LTD caused by the reduction 
of AMPA receptor exposure in the membrane is regulated by caspase activity6. From the first identification of 
caspase involvement in this process, most apoptotic members of the intrinsic pathway have been found to cor-
relate with synapse weakening6–8. In contrast, proteins that negatively regulate caspase activation, such as XIAP, 
impede LTD6. Our results support all these findings since the silencing of FAIM-L expression in hippocam-
pal neurons dramatically increased the induction of GluA2 internalization in response to NMDA treatment, as 
observed in XIAP-silenced cells. In agreement with these data, when XIAP protein levels were stabilized by over-
expressing FAIM-L, hippocampal neurons did not exhibit significant GluA2 internalization levels after NMDA 
treatment compared to non-treated neurons and, accordingly, they did not show LTD induction after NMDA 
treatment.
Nevertheless, our data not only describes the involvement of FAIM-L in the regulation of synaptic plasticity 
process LTD, but the participation of this DR antagonist in synaptic transmission. We only could detect that 
FAIM-L overexpression made the neurons prone to a more excited phenotype, as there was an increase in the 
amplitude of mEPCS, thereby indicating a perturbation of the correct function of the pre- and the post-synaptic 
synapse in this condition (Fig. 4A,B,C). This is the first time that a DR antagonist has been linked to the modula-
tion of synaptic transmission. The involvement of FAIM-L modulation of XIAP in the mechanism underlying this 
process is still unknown. There is no clear evidence pointing to XIAP as a modulator of synaptic transmission, and 
the mediation of caspases in this process has been discarded6. Thus, more experiments are required to elucidate 
whether FAIM-L performs this function through the stabilization of XIAP.
XIAP interacts and inhibits the effector caspases-3 and -7 and the initiator caspase-99–12. The physiological 
relevance of XIAP regulation of apoptosis has been related to the modulation of innate immunity, inflammation, 
and oncogenesis22,23; however, there is little evidence of its relevance in the CNS. During the development of the 
nervous system in Drosophila, the XIAP homolog DIAP-1 plays a key role in the regulation of caspase activity. 
DRONC caspase is constitutively active in fly neurons, and therefore DIAP1 is required to restrain its activ-
ity during neuronal growth. The inactivation of DIAP-1-mediated DRONC inhibition via DIAP-1 proteasomal 
degradation is crucial for the reshaping of dendritic arbors on ddAc sensory neurons during morphogenesis24. 
Unsain and collaborators demonstrated that the XIAP-caspase loop that regulates morphogenesis is phylogeneti-
cally conserved from flies to mammals13. Given our results, we propose that FAIM-L modulates this loop through 
the stabilization of XIAP. We observed that the overexpression of this DR antagonist not only reduces the axonal 
degeneration induced by NGF withdrawal but also impairs caspase-3 activation, which is consistent with the 
inhibition of XIAP degradation. Accordingly, cleavage of NF-66, a target of caspase-3 activation, is also subjected 
to interference (Figs 5 and 8).
As mentioned above, XIAP regulation of caspase activity in degenerating axons has been elegantly reported 
by Dr. Barker’s and Dr. Deshmukh’s labs4,13. Although both studies report higher caspase-3 activation and axon 
degeneration in XIAP KO mice, only one of them shows a decrease of XIAP levels after NGF withdrawal13. 
Moreover, in the study where the participation of caspase-3 in axon degeneration was stated, they did not 
observe any changes in XIAP axonal levels after NGF deprivation3. In this regard, we have observed low or not 
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evident XIAP down regulation after NGF withdrawal in DRG explant cultures; therefore, we have been unable 
to study if FAIM-L overexpression modulates XIAP levels in this context. Nevertheless, we observed a reduc-
tion in caspase-3 activation and a reduction in NF-66 degradation when we overexpressed FAIM-L. Taking into 
account these results, the observation that FAIM-L levels are decreased after NGF depletion, and the data shown 
in Fig. 8A, where we demonstrate that FAIM-L down-regulation by shRNA induces a faster axon degeneration, 
we believe that FAIM-L participates actively in this process.
The observation that NGF deprivation of DRG explants is accompanied by a downregulation of FAIM-L sug-
gests that the modulation of the stability of this protein or its expression participates in the degenerating cascade. 
In this context, little is known about the regulation of FAIM-L expression. We have reported that the MEK/ERK 
pathway is involved in the upregulation of FAIM-L after NGF-induced PC12 differentiation1, and, recently, it has 
been shown that the neural specificity of its expression is governed by NSR100 splicing factor25. However, these 
observations fall short of explaining the regulation of FAIM-L that occurs in the context of axon degeneration. 
Thus, it would be of interest to further characterize how this protein is regulated during this process in order to 
shed light on the mechanism that switches FAIM-L-induced XIAP stabilization on and off.
Taken together, our results indicate that, by regulating XIAP protein levels, FAIM-L plays a critical role in reg-
ulating non-apoptotic neural events, including axonal degeneration and pruning, and synaptic plasticity events, 
such as LTD. Moreover, through a mechanism that requires further clarification, we propose that FAIM-L partic-
ipates in synaptic transmission.
Methods
Plasmids. The plasmids pEIGW-EGFP-FAIM-L and pEIGW-EGFP-EMPTY were used for lentiviral over-
expression experiments26. And pLVTHM-XIAP-shRNA, pLVTHM-FAIM-L-shRNA or pLVTHM-scrambled-
shRNA were used for RNA interference2. The efficiency in gene expression manipulation by these vectors was 
tested in Segura et al.1, and Carriba et al.27.
Lentivirus production. Lentiviruses were produced as described by Segura et al.1.
Neuronal Culture. All procedures were performed in accordance with the guidelines approved by the 
Spanish Ministry of Science and Technology and following the European Community Council Directive 86/609 
EEC. All experimental protocols were approved by the Vall d’Hebron Institutional Review Board (CEIC) and the 
Departament d’Agricultura, Ramaderia, Pesca, Alimentació i Medi Natural of the Generalitat de Catalunya (15/14 
CEEA).
Hippocampal neuron cultures and infection. Hippocampal neuron cultures were prepared from mouse 
embryos at embryonic day (E) 15-16. Brains were dissected in PBS containing 0.6% glucose, and hippocampi 
were dissected out. After trypsin (Invitrogen) and DNase treatment (Roche Diagnostics), tissue pieces were dis-
sociated, and 50,000 cells were seeded onto 12-mm diameter coverslips coated with 0.5 mg/ml poly-L-lysine 
(Sigma-Aldrich). Neurons were cultured for 15–18 days in Neurobasal medium supplemented with B27 (Life 
Technologies), glutamine, 20 U/ml penicillin and 20 μ g/ml streptomycin (Sigma-Aldrich, Barcelona, Spain). 
The medium was further supplemented by adding 1/5 of the volume with conditioned medium from mature 
(> 14 DIV) hippocampal cultures.
Two consecutive lentiviral infections were performed. XIAP shRNA, FAIM-L shRNA or scrambled infection 
was performed 3 days before the internalization assay; FAIM-L-EGFP or empty-EGFP lentiviral infection was 
performed 24 h later. Medium containing viruses was changed 5 h after infection. The size of infected cells did not 
change under the conditions assayed. The percentage of infected cells (GFP-positive) was around 75%, and the 
efficiency of both FAIM-L overexpression and XIAP down-regulation was assessed by immunocytochemistry.
Campenot chamber assay of dorsal root ganglia neurons and posterior infection. The 
Campenot chamber assay was performed as described28, with minor modifications. In brief, poly-L-ornithine and 
laminin-coated Aclar embedded coverslips (Electron microscopy sciences) were scratched with a pin-rake (Tyler 
research), and a three-compartment Teflon divider was placed on silicone grease. Dissociated sensory neurons 
from E13 dorsal root ganglia (DRG) were plated in the central compartment using medium supplemented with 
10 ng/ml human NGF. The distal compartments were filled with medium containing 75 ng/ml human NGF. The 
next day, cultures were treated with 5 μ M cytosine arabinoside. On days 5 and 7, cultures were infected with the 
corresponding lentiviruses expressing scrambled, XIAP or FAIM-L shRNAs and EMPTY EGFP or FAIM-L EGFP 
overexpression vectors, respectively. To trigger local axonal degeneration, NGF-containing medium from axonal 
compartments was replaced with medium containing sheep anti-NGF 1:50 (Abcam). Cultures were fixed with 
4% paraformaldehyde 24 h after NGF removal and processed for β III-Tubulin (Covance) (1:4000) and GFP (Life 
technologies) (1:500) immunofluorescence. Alternatively, cells were collected for Western blot analysis.
Dorsal root ganglia explant culture. Explants culture were obtained from mouse embryos at E13. 
Embryos were dissected in L-15 and DRG were dissected out. Explants were plated on 48- or 24-well plates, 
which had been previously coated with poly-L-ornithine and laminin, for protein and immunochemistry analy-
sis, respectively. After dissection, explants were seeded with medium containing 25 ng/mL NGF and infected with 
lentiviral vectors expressing EMPTY-EGFP or FAIM-L EGFP. After 8 h, the medium was replaced by medium 
supplemented with 5 μ M cytosine arabinoside. At DIV 2, explants were subjected to NGF withdrawal, and protein 
and immunochemistry analysis were performed at 8 and 24 h.
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Quantification of Axon Viability. To measure the percentage of non-degenerating axons, double immu-
nostained (β III-Tubulin and GFP) visible axons were counted at the leading edge of the NGF-deprived com-
partment, and the value was normalized by the number of axons in the compartment containing NGF. Two-way 
ANOVA test followed by Bonferroni post-hoc test was used to calculate significant levels between the indicated 
groups.
GluA2 Internalization Assay and Surface Staining. Internalization assays were performed as 
described6, with minor modifications. Briefly, hippocampal neurons at 15–18 days DIV were incubated with 
antibodies against the N-terminus of GluA2 (2 μ g/ml, mouse monoclonal, clone 6C4, Millipore) for 30–60 min 
at 18–20 °C. After brief washing, neurons were either incubated with control medium or medium containing 
NMDA (50 μ M) for 15 min at 37 °C. Subsequently, they were fixed for 5 min at room temperature in paraformal-
dehyde (4%)/sucrose (4%) without permeabilization. Surface-remaining antibody-labeled receptors were visual-
ized by means of a 1-h incubation with saturated Cy5-secondary antibody (15 μ g/ml, Jackson ImmunoResearch). 
Neurons were permeabilized for 2 min with methanol (− 20 °C), and internalized antibody-labeled GluA2 
was detected by a 1-h incubation with Alexa 568-conjugated secondary antibody (1 μ g/ml, Invitrogen). 
Simultaneously, infected GFP-fluorescent neurons were stained with antibodies against GFP (5 μ g/ml, Invitrogen, 
rabbit polyclonal). Thus, the GFP fluorescence of infected neurons was enhanced by a 30 min incubation with 
Alexa 488-conjugated secondary antibodies (4 μ g/ml, Invitrogen). After staining, the coverslips were mounted in 
Mowiol (Sigma-Aldrich, Barcelona, Spain).
Image Acquisition and Analysis. Images were acquired using a Leica SP2 spectral confocal microscope 
with a 63X (NA 1.4) objective. A z-stack of images was obtained through various filter channels (Alexa-488, 
Alexa-568 and Cy5). Typically, 20–25 serial 2D images were recorded at 250-nm intervals. Image acquisition 
settings were identical in each experiment. FIJI software was used to make 2D projections from the z-stack of 
images. We measured the total integrated intensity of internalized GluA2 and surface-remaining GluA2 in the 
same region (which included the cell body and proximal dendrites within 20 μ m of the cell body) of infected 
(GFP-positive) neurons. A threshold was set on the basis of cell-free regions and was kept constant for all condi-
tions in each experiment. Statistical analysis was performed using the One-way ANOVA test followed by Tukey’s 
or the Newman-Keuls multiple comparison post-hoc test.
Immunocytochemistry and Western Blotting. FAIM-L overexpression, XIAP down-regulation, 
and their cross-regulation were tested by immunocytochemistry in infected hippocampal primary cultures. 
Immunocytochemistry was performed using anti-XIAP (1:500; BD Biosciences), anti-FAIM-L (1:500; in house), 
and rabbit anti-GFP (1:500; Invitrogen), followed by Alexa 568 and Alexa 488-coupled antibodies (1:500; 
Invitrogen). In DRG neurons, XIAP, FAIM-L, pan-ERK, NF66 and caspase-3 levels were assessed by Western blot 
using anti-XIAP (BD Biosciences; 1:20,000), anti-FAIM-L (in house; 1:2,000), anti-pan-ERK (BD Biosciences; 
1:20,000), anti-NF66 (Covance; 1:10,000), anti-caspase-3 (Cell Signaling; 1:1,000) and Histone H3 (Thermo 
Scientific; 1:40,000) antibodies.
Immunocytochemistry and Western Blotting data Analysis and Statistics. Results were analysed 
using Graphpad Prism, v5.0 (GraphPad Software Inc.). All data were given as mean ± standard error of mean 
(SEM) and represent the analysis of at least three independent experiments as directed in each specific case. 
Sample sizes were initially chosen taking into account means and standard deviations from preliminary results 
obtained from initial exploratory studies. Assuming a Type I error = 5%, and a statistical power ≥ 0.8 (80%) the 
sample size for all western blotting was 3, and for the immunocytochemistry experiments was ≥ 15 cells from 3 
independent experiments. Comparisons between two experimental groups were performed using unpaired t-test 
(2-tailed). Experimental groups of more than two were compared using one-way analysis of variance (ANOVA) 
followed by Tukey’s multiple comparison post-hoc test or two-way ANOVA followed by Bonferroni’s post-hoc test. 
Significance was defined as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0,0001.
Electrophysiological Recordings. For the electrophysiological recordings of cultured hippocampal 
pyramidal neurons (15–17 d.i.v.), coverslips were mounted in a recording chamber placed on the stage of an 
inverted microscope (Olympus, IX70; Olympus, London, UK or Zeiss, Axiovert 35 M; Oberkochen; Germany). 
Whole-cell patch-clamp currents were recorded with an Axopatch 200B amplifier – Digidata1322A Series inter-
face board using pClamp10 software (Molecular Devices Corporation, SunnyVale, CA). All recording were 
performed at room temperature (22–23 °C). Cells were continuously superfused with extracellular solution con-
taining (in mM): 140 NaCl, 3.5 KCl, 10 HEPES, 1 tetraethylammonium chloride (TEA), 20 glucose, 1.8 CaCl2, 
and 0.8 MgCl2 (pH 7.4 adjusted with NaOH). To isolate AMPAR-mediated mEPSCs, the following blockers were 
added to the extracellular solution: 1 μ M Tetrodotoxin (TTX; Abcam Biomedical, UK) to block evoked syn-
aptic transmission, 50 μ M D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5; Sigma-Aldrich; St. Louis, MO) 
to block NMDA receptors, and 100 μ M Picrotoxin (Sigma-Aldrich; St. Louis, MO) to block GABAA receptors. 
Recording electrodes were fabricated from borosilicate glass (PG150T-7.5; 1.5 mm o.d.; 1.16 mm i.d.; Harvard 
Apparatus Limit, Edenbridge, UK) pulled with a puller P-97 (Sutter Instrument Co., Novato, CA) and had a 
final resistance of 2.5–4.5 MΩ. Recordings were made using electrodes filled with an internal solution contain-
ing (in mM): 116 K-Gluconate, 6 KCl, 2 NaCl, 20 HEPES, 0.5 ethylene glycol tetraacetic acid (EGTA), 2 MgATP, 
0.3 Na2GTP (pH 7.3 with KOH). Hippocampal pyramidal neurons were chosen in basis of their pyramidal char-
acteristic morphology. Series resistance (Rs) was typically 10–20 MΩ, and was monitored at the beginning and at 
the end of the experiment. Cells that showed a change in Rs greater than 20% were rejected.
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Chem-LTD Induction. To induce chemical long-term depression (Chem-LTD) in pyramidal neuronal cul-
tures, NMDA was applied at 50 μ M for 5 min onto coverslips in physiological recording solution at room tem-
perature. Upon removal of NMDA-containing solution, coverslips were superfused with physiological solution 
containing blockers, and recordings were performed at time points ranging from 1 to 20 min. Data were grouped 
in 5-min clusters (1–5 min, 6–10 min, 11–15 and 16–20 min after NMDA application).
Electrophysiology Data Analysis and Statistics. mEPSCs were filtered at 2 KHz and digitized at 5 KHz. 
Data were analyzed using IGOR Pro (Wavemetrics Inc., OR, USA), together with Neuromatic (Jason Rothman, 
UCL). Events were detected using an amplitude threshold of 4–6 pA set according to the baseline current variance. 
For mEPSC amplitude analysis, only events with a monotonic fast rise (< 1.2 ms) and uncontaminated decay 
were included. When analyzing frequency, any event irrespective of rise time or overlapping decays was included. 
Statistical analysis was performed using GraphPad Prism version 5.0d for Mac OS X (GraphPad Software, San 
Diego California USA, www.graphpad.com). Data are presented in the text as the mean ± SEM from n recorded 
cells and in the figures as bar plots of the group mean, with error bars denoting the SEM. Statistical significance 
between two groups was examined using the non-parametric Mann-Whitney U test.
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